Birdwatch Note
2023-02-17 19:34:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Per the article referred to in the tweet, this was specific for reinfection, not initial infection. "Infection-acquired immunity cut the risk of hospitalization and death from a Covid reinfection by 88% for at least 10 months, the study found." https://www.nbcnews.com/health/health-news/natural-immunity-protective-covid-vaccine-severe-illness-rcna71027
Written by 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1626625168524050457
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1626666538437599234
- noteId - 1626666538437599234
- participantId - 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04
- noteAuthorParticipantId -
- createdAtMillis - 1676662499423
- tweetId - 1626625168524050457
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Per the article referred to in the tweet, this was specific for reinfection, not initial infection. "Infection-acquired immunity cut the risk of hospitalization and death from a Covid reinfection by 88% for at least 10 months, the study found." https://www.nbcnews.com/health/health-news/natural-immunity-protective-covid-vaccine-severe-illness-rcna71027
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-02-17 19:34:59 UTC (1676662499423) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-07 02:11:29 UTC (1678155089929) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-02-17 14:57:12 -0600 | 059EDE0FD4D34ACFE05703F6115F301BADBC55D1034ADA52CEFDCEC856D5C343 | Rating Details |
2023-02-17 20:56:24 -0600 | 2642006EB4CE8C7D36E6B3E955B2CC983E182C2D3F12D4E934C8173EA37C08C7 | Rating Details |
2023-02-18 03:16:03 -0600 | 3440E327FFC09396E77E3C806B2CE63500A27905ABDA4DA599C2EFB3935307B4 | Rating Details |
2023-02-18 14:11:07 -0600 | 39F587E5B62482796083E25E3829E9063A376EEE6CC80AAAE3FC65EF767C9F6B | Rating Details |
2023-02-17 14:13:43 -0600 | 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 | Rating Details |
2023-02-18 06:38:43 -0600 | 547FBF0AE8C2B0184DEA10226C726B2B83209042760154C187D2BFF59F1A82CF | Rating Details |
2023-02-17 20:15:02 -0600 | 5970C9E3A232F6E6CB8621061C7CA9099FBC5FDB07035A44889CF6B31C552867 | Rating Details |
2023-02-17 14:06:37 -0600 | 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 | Rating Details |
2023-02-18 13:39:21 -0600 | 669707F955815F3AE036CE8047DEFBD65D150CF91539597B5121CAC5E4C814F8 | Rating Details |
2023-02-18 02:43:13 -0600 | 6B8C287E76E2C23D3E1B6B779BB6034087EE278C1C81CC134D523A30AE9D656A | Rating Details |
2023-02-17 22:39:10 -0600 | 6D1D45E5263A9DDD3915166AF291C972F1CCB3F96FA149D42D04785143F1F56E | Rating Details |
2023-02-17 14:25:50 -0600 | 6ECA11AABB2094A7654E37626302B3E83430CBFFCFCE227CC1B8014834A73D01 | Rating Details |
2023-02-18 10:30:01 -0600 | 72B76DCAF88797DA16A68A597AE5DD3391036DED95CE8FC38BBC134FFF6959EE | Rating Details |
2023-02-18 04:08:23 -0600 | 793B627FA791FB5070B2D080B45C8592200D6CA5A3DF3CDCB57743F9CAE39AAD | Rating Details |
2023-02-17 16:08:44 -0600 | 7FAABCAE087000DDE4D5681C4C60267730B376A126A37618AEDAD939950F3DEF | Rating Details |
2023-02-17 16:45:03 -0600 | A9B92910FBB0D447D2238EDA88ADA3C4D14C0B8C99516EDD6891AC1263E3536E | Rating Details |
2023-02-17 17:28:20 -0600 | B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A | Rating Details |
2023-02-17 16:51:03 -0600 | B4034C78831384EF5129F31116A45A33887F8C60AF99FF23092086781089FEFB | Rating Details |
2023-02-17 17:02:07 -0600 | B6383C5A0F1F7B0C425678E35E7FDB4D855931FCDF6A439A5E89F436B640EB16 | Rating Details |
2023-02-17 13:37:48 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
2023-02-17 15:18:25 -0600 | C6B8842E464FAF2AD0BA283AF60A1A1EE6F5D3A09C514C92D4CCC2CE4E451182 | Rating Details |
2023-02-18 10:03:25 -0600 | CA2719F7614F22AEA1DA870603ED452EB7A0D66597AE8DFE2E73BE106F26B281 | Rating Details |
2023-02-17 19:29:16 -0600 | D9C17D57ED8946A3C56DFD6BF9A3D7A98D9010069EAD3E94B41744DB1BC3BFF9 | Rating Details |
2023-02-19 11:47:19 -0600 | E2EBB8CD97237FF403E081CB6C313A7660B47FD49923CA7E30C31FFE044C09AD | Rating Details |
2023-02-18 14:21:44 -0600 | F13DE5F0BC6747304C6E2FB90C0258FABD5AD5021950FF5CB2DC73C174764E5E | Rating Details |
2023-02-17 14:05:58 -0600 | F74824CBC9B020AD6D6FC1CC3D7992D1049369A4BBB6E1D1043C3FC1F66AD863 | Rating Details |
2023-02-18 04:06:38 -0600 | F810B9A117A15B206340CC72B29D65263DC4B812622393BFCBE22D0EE5EE3DFF | Rating Details |
2023-02-17 15:18:25 -0600 | Rating Details | |
2023-02-17 14:05:58 -0600 | Rating Details | |
2023-02-17 20:56:24 -0600 | Rating Details | |
2023-02-19 11:47:19 -0600 | Rating Details | |
2023-02-17 14:57:12 -0600 | Rating Details | |
2023-02-17 13:37:48 -0600 | Rating Details | |
2023-02-17 14:13:43 -0600 | Rating Details | |
2023-02-17 19:29:16 -0600 | Rating Details | |
2023-02-18 06:38:43 -0600 | Rating Details | |
2023-02-17 14:25:50 -0600 | Rating Details | |
2023-02-17 16:51:03 -0600 | Rating Details | |
2023-02-18 10:03:25 -0600 | Rating Details | |
2023-02-18 03:16:03 -0600 | Rating Details | |
2023-02-18 04:06:38 -0600 | Rating Details | |
2023-02-17 16:45:03 -0600 | Rating Details | |
2023-02-18 14:11:07 -0600 | Rating Details | |
2023-02-17 17:28:20 -0600 | Rating Details | |
2023-02-18 14:21:44 -0600 | Rating Details | |
2023-02-17 17:02:07 -0600 | Rating Details | |
2023-02-17 22:39:10 -0600 | Rating Details | |
2023-02-17 14:06:37 -0600 | Rating Details | |
2023-02-18 04:08:23 -0600 | Rating Details | |
2023-02-18 02:43:13 -0600 | Rating Details | |
2023-02-17 16:08:44 -0600 | Rating Details | |
2023-02-18 13:39:21 -0600 | Rating Details | |
2023-02-17 20:15:02 -0600 | Rating Details | |
2023-02-18 10:30:01 -0600 | Rating Details |